Analytical Data
-
基因名
TMEM184B
- Application
-
别名
TMEM184B; C22orf5; PSEC0108; Transmembrane Protein 184B; Putative MAPK-activating Protein FM08
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y519
-
表达区间
1-407 aa
-
氨基酸序列
MTVRGDVLAPDPASPTTAAASPSVSVIPEGSPTAMEQPVFLMTTAAQAISGFFVWTALLITCHQIYMHLRCYSCPNEQRYIVRILFIVPIYAFDSWLSLLFFTNDQYYVYFGTVRDCYEALVIYNFLSLCYEYLGGESSIMSEIRGKPIESSCMYGTCCLWGKTYSIGFLRFCKQATLQFCVVKPLMAVSTVVLQAFGKYRDGDFDVTSGYLYVTIIYNISVSLALYALFLFYFATRELLSPYSPVLKFFMVKSVIFLSFWQGMLLAILEKCGAIPKIHSARVSVGEGTVAAGYQDFIICVEMFFAALALRHAFTYKVYADKRLDAQGRCAPMKSISSSLKETMNPHDIVQDAIHNFSPAYQQYTQQSTLEPGPTWRGGAHGLSRSHSLSGARDNEKTLLLSSDDEF
-
分子量
71.17 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TMEM184B is a member of the transmembrane protein family that has gained attention due to its potential role in various biological processes, including cell signaling, membrane dynamics, and disease pathology. Research has indicated that TMEM184B may be involved in immune responses and cancer development, making it a target of interest for therapeutic interventions. Despite its significance, the functional mechanisms of TMEM184B remain largely unexplored. Recent studies have focused on the recombinant expression of TMEM184B to better understand its structure and biological functions, facilitating the exploration of its interactions with other proteins and cellular pathways. Recombinant TMEM184B proteins enable high-throughput assays and structural studies, providing insights into its possible roles in pathophysiological conditions. By elucidating the functional characteristics of TMEM184B, researchers aim to pave the way for potential clinical applications, including targeted therapies and biomarker development in diseases where TMEM184B is implicated. Thus, understanding the biology of TMEM184B through recombinant protein studies is crucial for advancing knowledge in cell biology and developing innovative treatment strategies.
